Cancer research
Recent research published in the journal Clinical and Experimental Medicine has highlighted the potential of exosome-based immunotherapy in treating hepatocellular carcinoma (HCC), a type of liver cancer that is the third leading cause of cancer-associated mortality globally. The study, conducted by researchers from the Department of Pathology at Xixi Hosp
Cancer research
Researchers at the First People's Hospital have published a new study on liver cancer treatment, focusing on the use of interstitial brachytherapy as a viable option for patients with advanced-stage disease. The study, published in Frontiers in Oncology, highlights the effectiveness of interstitial brachytherapy in treating gluteus medius
Cancer research
Research conducted by Sichuan University and published in Frontiers in Immunology has demonstrated the efficacy of combining stereotactic body radiotherapy (SBRT) with immunotherapy in treating metastatic hepatocellular carcinoma (HCC). In a case study, a patient with HBV-related advanced HCC achieved significant progression-free survival and overall survival with the combination treatment.
Cancer research
Researchers at Fudan University have shed light on the molecular mechanisms behind liver cancer progression, with a focus on the role of N6-methyladenosine (m6A) modifications and the demethylase FTO. The study analyzed m6A expression in a cohort of 323 HCC patients and found that high m6A levels were correlated with
Hepatocellular carcinoma
The study explored the role of GTF3C2 in hepatocellular carcinoma (HCC), revealing its overexpression in HCC tissues and its positive correlation with advanced tumor stages and high tumor grades. GTF3C2 expression was found to be upregulated in HCC tissues, and patients with high GTF3C2 expression had significantly worse survival outcomes.
